References
- von Ardenne M., Rieger F. Mathematical in vivo theory of tumour formation. Zeitschrift fur Noturforschung 1966; 21B: 472–482
- Bak B., Skaarup S. The substitution structure of ethyleneimine. Journal of Molecular Structure 1971; 3: 55–198
- Bingham R. C., Dewar M. J. S., Lo D. H. Ground states of molecules XXV. MINDO/3: An improved version of the MINDO semi‐empirical SCF‐MO method. Journal of the American Chemical Society 1975; 97: 1285–1293
- Burke J. F., Whitehouse M. W. Concerning the differences in uncoupling activity of isomeric dinitrophenols. Biochemical Pharmacology 1967; 16: 209–211
- Cammarata A. Quantum perturbation theory and linear free energy relationships in the study of drug action. Molecular Orbital Studies of Chemical Pharmacology, L. B. Kier. Springer‐Verlag, New York 1970; 156–190
- Carsten M. E., Eisen H. N. The interaction of dinitrobenzene derivatives with bovine serum albumin. Journal of the American Chemical Society 1953; 75: 4451–4456
- Clark D. T. Non empirical LCAO‐MO‐SCF calculations with Gaussian type functions on some three membered ring heterocycles. Theoretica Chimica Acta 1969; 15: 225–234
- Cobb L. M., Connors T. A., Elson L. A., Khan A. M., Mitchley B. C. V., Ross W. C. J., Whisson M. E. 2,4‐Dinitro‐5‐ethyleneiminobenzamide (CB 1954): A potent and selective inhibitor of the growth of the Walker carcinoma 256. Biochemical Pharmacology 1969; 18: 1519–1527
- Connors T. A., Hickman J. A., Jarman M., Melzack D. H., Ross W. C. J. The metabolism of the anti‐tumour agent 1(1‐aziridinyl)‐2,4‐dinitrobenzene (CB 1937). Biochemical Pharmacology 1973; 24: 1665–1670
- Connors T. A., Mandel H. G., Melzack D. H. Studies on the reversal of the selective anti‐tumour effect of the aziridinyl derivative CB 1954 by 4‐amino‐5‐imidazole carboxamide. International Journal of Cancer 1972; 9: 126–132
- Connors T. A., Melzack D. M. Studies on the mechanism of action of 5‐aziridinyl‐2,4‐dinitrobenzamide (CB 1954), a selective inhibitor of the Walker tumour. International Journal of Cancer 1971; 7: 86–92
- Dermer O. C., Ham G. E. Ethylenimine and Other Aziridines. Academic Press, New York 1969
- Eden M., Haines B., Kahler H. The pH of rat tumours measured in vivo. Journal of the National Cancer Institute 1955; 16: 541–556
- Emmelot P. The molecular basis of cancer chemotherapy. Molecular Pharmacology, E. J. Ariens. Academic Press, New York 1964; Vol. 2: 55–198
- Hickman J. A. Structure activity relationships in a series of anti‐neoplastic dinitrophenyl aziridines—protein binding studies. Biochemical Pharmacology 1974; 23: 2833–2838
- Iball J., Scrimgeour S. N., Williams B. C. The crystal and molecular structure of 2,4‐dinitro‐5‐ethyleneiminobenzamide. Acta Crystallographia 1975; B31: 1121–1123
- Jarman M., Melzack D. H., Ross W. C. J. The metabolism of the anti‐tumour agent 5(1‐aziridinyl)2,4‐dinitrobenzamide. Biochemical Pharmacology 1976; 25: 2475–2478
- Khan A. H., Ross W. C. J. Tumour‐growth inhibitory nitrophenyl aziridines and related compounds: structure‐activity relationship. Chemical‐Biological Interactions 1970; 1: 27–47
- Khan A. H., Ross W. C. J. Tumour‐growth inhibitory nitrophenyl aziridines and related compounds: structure‐activity relationships. Chemical‐Biological Interactions 1972; 4: 11–22
- Lehn J. M., Munsch B., Millie P., Veillard A. Theoretical conformational analysis III. Nitrogen inversion: An ab initio SCF‐LCAO‐MO study of aziridine and oxaziridine. Theoretica Chimica Acta 1969; 13: 313–339
- Mandel H. G., Connors T. A., Melzack D. H., Merai K. Studies on the mechanism of action of 5‐aziridinyl‐2,4‐dinitrobenzamide in tumours cells. Cancer Research 1974; 34: 275–280
- Morokuma H., Fukui K., Kato H. The electronic structures and antioxidizing activities of substituted phenols. Bulletin of the Chemical Society of Japan 1963; 36: 541–546
- Ross W. C. J. The chemistry of cytotoxic alkylating agents. Cancer Research 1953; 1: 397–449
- Schloerb P. R., Blackburn G. L., Grantham J. J., Mallard D. S., Cage G. K. Intracellular pH and buffering capacity of the Walker‐256 carcinoma. Surgery 1965; 58: 5–11
- Shapot V. S. Some biochemical aspects of the relationship between the tumour and the host. Advances in Cancer Research 1972; 15: 253–286
- Stock J. A. Design of tumour‐inhibitory alkylating drugs. Drug Design, E. J. Ariens. Academic Press, New York 1971; Vol. 2: 532–571
- Sutton L. E. Tables of interatomic distances and configurations in molecules and ions. Chemical Society Special Publication 1958; 1: 1, London
- Tisdale M. J. Alkylating analogues of the tumour inhibitor 5‐aziridino 2,4‐dinitrobenzamide. Chemico‐Biological Interactions 1971; 3: 95–107
- Yates K., Stevens J. B. The ionization behaviour of amides in concentrated sulphuric acids. Canadian Journal of Chemistry 1965; 43: 529–537